Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence

Human Molecular Genetics

Volumn 14, Issue 12, 2005, Pages 1691-1698

  Ma, Jennie Z ^a   Beuten, Joke ^a   Payne, Thomas J ^b   Dupont, Randolph T ^c   Elston, Robert C ^d   Li, Ming D ^a,e  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c University of Memphis   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e MSC 7792 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; NICOTINE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CIGARETTE SMOKING; COMPUTER PROGRAM; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; TOBACCO DEPENDENCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; DOPA DECARBOXYLASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MODELS, GENETIC; NUCLEAR FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; TOBACCO USE DISORDER;

EID: 21244474712     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi177     Document Type: Article

References (51)

1. Twombly, R. (2002) World Health Organization takes on 'tobacco epidemic'. J. Natl. Cancer Inst., 94, 644-646.
2. WHO (2002) The World Health Report 2002. World Health Organization.
3. Mokdad, A.H., Marks, J.S., Stroup, D.F. and Gerberding, J.L. (2004) Actual causes of death in the United States, 2000. JAMA, 291, 1238-1245.
4. Benowitz, N.L. (1988) Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. N. Engl. J. Med., 319, 1318-1330.
5. Sullivan, P.F. and Kendler, K.S. (1999) The genetic epidemiology of smoking. Nicotine Tob. Res., 1(Suppl. 2), S51-S57 (discussion S69-S70).
6. Li, M.D., Cheng, R., Ma, J.Z. and Swan, G.E. (2003) A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction, 98, 23-31.
7. Niu, T., Chen, C., Ni, J., Wang, B., Fang, Z., Shao, H. and Xu, X. (2000) Nicotine dependence and its familial aggregation in Chinese. Int. J. Epidemiol., 29, 248-252.
8. Hatchell, P.C. and Collins, A.C. (1980) The influence of genotype and sex on behavioral sensitivity to nicotine in mice. Psychopharmacology (Berl), 71, 45-49.
9. Marks, M.J., Stitzel, J.A. and Collins, A.C. (1989) Genetic influences on nicotine responses. Pharmacol. Biochem. Behav., 33, 667-678.
10. Robinson, S.F., Marks, M.J. and Collins, A. C. (1996) Inbred mouse strains vary in oral self-selection of nicotine. Psychopharmacology (Berl), 124, 332-339.
11. Uhl, G.R., Vandenbergh, D.J., Rodriguez, L.A., Miner, L. and Takahashi, N. (1998) Dopaminergic genes and substance abuse. Adv. Pharmacol., 42, 1024-1032.
12. Picciotto, M.R. (2003) Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol. Sci., 24, 493-499.
13. Corrigall, W.A., Franklin, K.B., Coen, K.M. and Clarke, P.B. (1992) The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl), 107, 285-289.
14. Pontieri, F.E., Tanda, G., Orzi, F. and Di Chiara, G. (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature, 382, 255-257.
15. Salokangas, R.K., Vilkman, H., Ilonen, T., Taiminen, T., Bergman, J., Haaparanta, M., Solin, O., Alanen, A., Syvalahti, E. and Hietala, J. (2000) High levels of dopamine activity in the basal ganglia of cigarette smokers. Am. J. Psychiatry, 157, 632-634.
16. Brody, A.L., Olmstead, R.E., London, E.D., Farahi, J., Meyer, J.H., Grossman, P., Lee, G.S., Huang, J., Hahn, E.L. and Mandelkern, M.A. (2004) Smoking-induced ventral striatum dopamine release. Am. J. Psychiatry, 161, 1211-1218.
17. Christenson, J.G., Dairman, W. and Udenfriend, S. (1972) On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine). Proc. Natl Acad. Sci. USA, 69, 343-347.
18. Craig, S.P., Thai, A.L., Weber, M. and Craig, I.W. (1992) Localisation of the gene for human aromatic L-amino acid decarboxylase (DDC) to chromosome 7p13 → p11 by in situ hybridisation. Cytogenet. Cell Genet., 61, 114-116.
19. Sumi-Ichinose, C., Ichinose, H., Takahashi, E., Hori, T. and Nagatsu, T. (1992) Molecular cloning of glenomic DNA and chromosomal assignment of the gene for human aromatic L-amino acid decarboxylase, the enzyme for catecholamine and serotonin biosynthesis. Biochemistry, 31, 2229-2238.
20. Berry, M.D., Juorio, A.V., Li, X.M. and Boulton, A.A. (1996) Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme. Neurochem. Res., 21, 1075-1087.
21. Borglum, A.D., Hampson, M., Kjeldsen, T.E., Muir, W., Murray, V., Ewald, H., Mors, O., Blackwood, D. and Kruse, T.A. (2001) Dopa decarboxylase genotypes may influence age at onset of schizophrenia. Mol. Psychiatry, 6, 712-717.
22. Zhang, B., Jia, Y., Yuan, Y., Yu, X., Xu, Q. and Shen, Y. (2004) No association between polymorphisms in the DDC gene and paranoid schizophrenia in a northern Chinese population. Psychiatr. Genet., 14, 161-163.
23. Borglum, A.D., Bruun, T.G., Kjeldsen, T.E., Ewald, H., Mors, O., Kirov, G., Russ, C., Freeman, B., Collier, D.A. and Kruse, T.A. (1999) Two novel variants in the DOPA decarboxylase gene: association with bipolar affective disorder. Mol. Psychiatry, 4, 545-551.
24. Jahnes, E., Muller, D.J., Schulze, T.G., Windemuth, C., Cichon, S., Ohlraun, S., Fangerau, H., Held, T., Maier, W., Propping, P. et al. (2002) Association study between two variants in the DOPA decarboxylase gene in bipolar and unipolar affective disorder. Am. J. Med. Genet., 114, 519-522.
25. Borglum, A.D., Kirov, G., Craddock, N., Mors, O., Muir, W., Murray, V., McKee, I., Collier, D.A., Ewald, H., Owen, M.J. et al. (2003) Possible parent-of-origin effect of Dopa decarboxylase in susceptibility to bipolar affective disorder. Am. J. Med. Genet. B: Neuropsychiatr. Genet., 117, 18-22.
26. Hawi, Z., Foley, D., Kirley, A., McCarron, M., Fitzgerald, M. and Gill, M. (2001) Dopa decarboxylase gene polymorphisms and attention deficit hyperactivity disorder (ADHD): no evidence for association in the Irish population. Mol. Psychiatry, 6, 420-424.
27. Li, M.D., Ma, J.Z., Cheng, R., Dupont, R., Williams, K.C., Payne, T.J. and Elston, R.C. (2003) A genome wide scan to identify loci for smoking quantity in the Framingham Heart Study populations. BMC Genet., 4(Suppl. I), S103.
28. Li, M.D., Ma, J.Z. and Beuten, J. (2004) Progress in searching for susceptibility loci and genes for smoking-related behaviour. Clin. Genet., 66, 382-392.
29. Wang, D., Ma, J.Z. and Li, M.D. (2005) Mapping and verification of susceptibility loci for smoking quantity using permutation linkage analysis. Pharmacogenomics J., in press.
30. Benowitz, N.L., Perez-Stable, E.J., Fong, I., Modin, G., Herrera, B. and Jacob, P., III (1999) Ethnic differences in N-glucuronidation of nicotine and cotinine. J. Pharmacol. Exp. Ther., 291, 1196-1203.
31. Gabriel, S.B., Schaffner, S.F., Nguyen, H., Moore, J.M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M. et al. (2002) The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.
32. Tyndale, R.F. (2003) Genetics of alcohol and tobacco use in humans. Ann. Med., 35, 94-121.
33. Lerman, C. and Berrettini, W. (2003) Elucidating the role of genetic factors in smoking behavior and nicotine dependence. Am. J. Med. Genet. B: Neuropsychiatr. Genet., 118, 48-54.
34. Munafo, M.R., Clark, T.G., Johnstone, E.C., Murphy, F.G. and Walton, R.T. (2004) The genetics basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res., 6, 583-597.
35. Niu, T., Qin, Z.S., Xu, X. and Liu, J.S. (2002) Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am. J. Hum. Genet., 70, 157-169.
36. Clark, A.G. (2004) The role of haplotypes in candidate gene studies. Genet. Epidemiol., 27, 321-333.
37. Cardon, L.R. and Bell, J.I. (2001) Association study designs for complex diseases. Nat. Rev. Genet., 2, 91-99.
38. Hirschhorn, J.N., Lohmueller, K., Byrne, E. and Hischhorn, K. (2002) A comprehensive review of genetic association studies. Genet. Med., 4, 45-61.
39. Ioannidis, J.P., Trikalinos, T.A., Ntzani, E.E. and Contopoulos-Ioannidis, D.G. (2003) Genetic associations in large versus small studies: an empirical assessment. Lancet, 361, 567-571.
40. Burchard, E.G., Ziv, E., Coyle, N., Gomez, S.L., Tang, H., Karter, A.J., Mountain, J.L., Perez-Stable, E.J., Sheppard, D. and Risch, N. (2003) The importance of race and ethnic background in biomedical research and clinical practice. N. Engl. J. Med., 348, 1170-1175.
41. Bamshad, M., Wooding, S., Salisbury, B.A. and Stephens, J.C. (2004) Deconstructing the relationship between genetics and race. Nat. Rev. Genet., 5, 598-609.
42. Heatherton, T.F., Kozlowski, L.T., Frecker, R.C. and Fagerstrom, K.O. (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br. J. Addict., 86, 1119-1127.
43. Moolchan, E.T., Radzius, A., Epstein, D.H., Uhl, G., Gorelick, D.A., Cadet, J.L. and Henningfield, J.E. (2002) The Fagerstrom test for nicotine dependence and the diagnostic interview schedule: do they diagnose the same smokers? Addict. Behav., 27, 101-113.
44. Swan, G.E., Hudmon, K.S., Jack, L.M., Hemberger, K., Carmelli, D., Khroyan, T.V., Ring, H.Z., Hops, H., Andrews, J.A., Tildesley, E. et al. (2003) Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation. Cancer Epidemiol. Biomarkers Prev., 12, 994-1005.
45. Beuten, J., Ma, J.Z., Payne, T.J., Dupont, R.T., Crews, K.M., Somes, G., Williams, N.J., Elston, R.C. and Li, M.D. (2005) Single- and multilocus allelic variants within the GABAB receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. Am. J. Hum. Genet., 76, 859-864.
46. O'Connell, J.R. and Weeks, D.E. (1998) PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet., 63, 259-266.
47. Barrett, J.C., Fry, B., Maller, J. and Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
48. Laird, N.M., Horvath, S. and Xu, X. (2000) Implementing a unified approach to family-based tests of association. Genet. Epidemiol., 19(Suppl. 1), S36-S42.
49. Lange, C., Silverman, E.K., Xu, X., Weiss, S.T. and Laird, N.M. (2003) A multivariate family-based association test using generalized estimating equations: FBAT-GEE. Biostatistics, 4, 195-206.
50. Horvath, S., Xu, X., Lake, S.L., Silverman, E.K., Weiss, S.T. and Laird, N.M. (2004) Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet. Epidemiol., 26, 61-69.
51. Nyholt, D.R. (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet., 74, 765-769.